Open Access iconOpen Access

ARTICLE

crossmark

Automated Leukemia Screening and Sub-types Classification Using Deep Learning

by Chaudhary Hassan Abbas Gondal1,*, Muhammad Irfan2, Sarmad Shafique3, Muhammad Salman Bashir4, Mansoor Ahmed1, Osama M.Alshehri5, Hassan H. Almasoudi5, Samar M. Alqhtani6, Mohammed M. Jalal7, Malik A. Altayar7, Khalaf F. Alsharif8

1 Department of Computer Science, COMSATS University Islamabad, 44000, Pakistan
2 Electrical Engineering Department, College of Engineering, Najran University, Najran, 61441, Saudi Arabia
3 Control, Automotive and Robotics Lab, National Center of Robotics and Automation (NCRA HEC), Mirpur, Pakistan Mirpur University of Science and Technology (MUST), Mirpur, Pakistan
4 Department of Computer Science, Virtual University of Pakistan, Lahore, 54000, Pakistan
5 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Najran University, Najran, 61441, Saudi Arabia
6 Department of Information Systems, College of Computer Science and Information Systems, Najran University, Najran, 61441, Saudi Arabia
7 Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia
8 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia

* Corresponding Author: Chaudhary Hassan Abbas Gondal. Email: email

Computer Systems Science and Engineering 2023, 46(3), 3541-3558. https://doi.org/10.32604/csse.2023.036476

Abstract

Leukemia is a kind of blood cancer that damages the cells in the blood and bone marrow of the human body. It produces cancerous blood cells that disturb the human’s immune system and significantly affect bone marrow’s production ability to effectively create different types of blood cells like red blood cells (RBCs) and white blood cells (WBC), and platelets. Leukemia can be diagnosed manually by taking a complete blood count test of the patient’s blood, from which medical professionals can investigate the signs of leukemia cells. Furthermore, two other methods, microscopic inspection of blood smears and bone marrow aspiration, are also utilized while examining the patient for leukemia. However, all these methods are labor-intensive, slow, inaccurate, and require a lot of human experience and dedication. Different authors have proposed automated detection systems for leukemia diagnosis to overcome these limitations. They have deployed digital image processing and machine learning algorithms to classify the cells into normal and blast cells. However, these systems are more efficient, reliable, and fast than previous manual diagnosing methods. However, more work is required to classify leukemia-affected cells due to the complex characteristics of blood images and leukemia cells having much intra-class variability and inter-class similarity. In this paper, we have proposed a robust automated system to diagnose leukemia and its sub-types. We have classified ALL into its sub-types based on FAB classification, i.e., L1, L2, and L3 types with better performance. We have achieved 96.06% accuracy for subtypes classification, which is better when compared with the state-of-the-art methodologies.

Keywords


Cite This Article

APA Style
Gondal, C.H.A., Irfan, M., Shafique, S., Bashir, M.S., Ahmed, M. et al. (2023). Automated leukemia screening and sub-types classification using deep learning. Computer Systems Science and Engineering, 46(3), 3541-3558. https://doi.org/10.32604/csse.2023.036476
Vancouver Style
Gondal CHA, Irfan M, Shafique S, Bashir MS, Ahmed M, M.Alshehri O, et al. Automated leukemia screening and sub-types classification using deep learning. Comput Syst Sci Eng. 2023;46(3):3541-3558 https://doi.org/10.32604/csse.2023.036476
IEEE Style
C. H. A. Gondal et al., “Automated Leukemia Screening and Sub-types Classification Using Deep Learning,” Comput. Syst. Sci. Eng., vol. 46, no. 3, pp. 3541-3558, 2023. https://doi.org/10.32604/csse.2023.036476



cc Copyright © 2023 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 863

    View

  • 649

    Download

  • 0

    Like

Share Link